We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+7.12%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$20.1B
AUM Growth
-$26B
(-56%)
Cap. Flow
-$34.7B
Cap. Flow
% of AUM
-172.71%
Top 10 Holdings %
Top 10 Hldgs %
37.49%
Holding
2,693
New
259
Increased
178
Reduced
1,071
Closed
1,170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$75M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$66.9M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$64.8M |
| 4 |
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
|
+$50.3M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$47.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.53B |
| 2 |
Microsoft
MSFT
|
+$1.91B |
| 3 |
Apple
AAPL
|
+$1.42B |
| 4 |
Amazon
AMZN
|
+$1.08B |
| 5 |
Meta Platforms (Facebook)
META
|
+$836M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.49% |
| 2 | Consumer Discretionary | 8.59% |
| 3 | Communication Services | 8.54% |
| 4 | Healthcare | 6.84% |
| 5 | Financials | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Castle Biosciences
CSTL
$933M
| $17.4K | ﹤0.01% |
824
-10,908
| -93% | -$243K |
|
|
ITOS
1402
DELISTED
iTeos Therapeutics
ITOS
| $17.3K | ﹤0.01% |
1,113
-10,185
| -90% | -$146K |
|
1403
Regenxbio
RGNX
$704M
| $17.1K | ﹤0.01% |
1,471
-168,747
| -99% | -$2.63M |
|
1404
Phinia Inc
PHIN
$2.7B
| $17.1K | ﹤0.01% |
+440
| New | +$18.1K |
|
1405
Mineralys Therapeutics
MLYS
$2.31B
| $17K | ﹤0.01% |
+1,482
| New | +$18.7K |
|
|
WSR
1406
DELISTED
Whitestone REIT
WSR
| $16.8K | ﹤0.01% |
1,295
-19,064
| -94% | -$234K |
|
1407
Humacyte
HUMA
$148M
| $16.7K | ﹤0.01% |
+3,555
| New | +$18.5K |
|
|
GOOD
1408
Gladstone Commercial Corp
GOOD
$641M
| $16.3K | ﹤0.01% |
1,152
-16,939
| -94% | -$236K |
|
|
YMAB
1409
DELISTED
Y-mAbs Therapeutics
YMAB
| $16.2K | ﹤0.01% |
+1,310
| New | +$17.7K |
|
1410
HUTCHMED
HCM
$2.11B
| $16.1K | ﹤0.01% |
+926
| New | +$17.1K |
|
|
XRN
1411
Chiron Real Estate Inc
XRN
$484M
| $16K | ﹤0.01% |
359
-5,725
| -94% | -$249K |
|
|
TIGR
1412
UP Fintech Holding
TIGR
$833M
| $15.9K | ﹤0.01% |
+3,686
| New | +$14.5K |
|
1413
Savara
SVRA
$1.08B
| $15.7K | ﹤0.01% |
+4,126
| New | +$18.4K |
|
|
THRD
1414
DELISTED
Third Harmonic Bio
THRD
| $15.7K | ﹤0.01% |
+1,223
| New | +$15.1K |
|
1415
Replimune Group
REPL
$1.42B
| $15.6K | ﹤0.01% |
1,834
-37,356
| -95% | -$260K |
|
1416
SIGA Technologies
SIGA
$207M
| $15.6K | ﹤0.01% |
2,123
-19,738
| -90% | -$161K |
|
|
CNTA
1417
DELISTED
Centessa Pharmaceuticals
CNTA
| $15.5K | ﹤0.01% |
+1,730
| New | +$16.4K |
|
|
HUYA
1418
Huya Inc
HUYA
$538M
| $15.5K | ﹤0.01% |
4,028
-180,602
| -98% | -$850K |
|
|
OLPX
1419
DELISTED
Olaplex Holdings
OLPX
| $15.4K | ﹤0.01% |
+9,726
| New | +$15.5K |
|
1420
Marathon Digital Holdings
MARA
$3.56B
| $15.4K | ﹤0.01% |
774
-794,354
| -100% | -$15.1M |
|
|
LKFT
1421
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
| $15.3K | ﹤0.01% |
+607
| New | +$17.2K |
|
1422
Adaptive Biotechnologies
ADPT
$3.89B
| $15.2K | ﹤0.01% |
4,400
-46,079
| -91% | -$146K |
|
1423
Allogene Therapeutics
ALLO
$683M
| $15.2K | ﹤0.01% |
6,233
-355,680
| -98% | -$1.05M |
|
|
KALV
1424
DELISTED
KalVista Pharmaceuticals
KALV
| $15.2K | ﹤0.01% |
1,260
-9,375
| -88% | -$109K |
|
|
FPI
1425
Farmland Partners
FPI
$425M
| $15.1K | ﹤0.01% |
1,318
-23,221
| -95% | -$256K |
|
Similar funds
BC
Mirae Asset Global Investments's Q2 2024 Portfolio in Review
As of Q2 2024, Mirae Asset Global Investments held 2,693 positions worth $20.1B, down 56% from $46.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments withdrew a net $34.7B in Q2 2024, closing 1,170 positions and reducing 1,071 holdings. Its most notable exit was Vanguard Russell 2000 ETF, an estimated $449M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Mirae Asset Global Investments opened a new position in State Street SPDR Portfolio S&P 500 Value ETF worth $15.6M.
- Mirae Asset Global Investments's largest Q2 2024 buy was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $15.6M.
- Mirae Asset Global Investments added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $75M increase.
- Mirae Asset Global Investments's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $2.53B.
- Mirae Asset Global Investments fully exited Vanguard Russell 2000 ETF in Q2 2024, selling an estimated $449M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $20.1B portfolio in Q2 2024.
- Mirae Asset Global Investments opened 259 new positions and closed 1,170 in Q2 2024.
- Mirae Asset Global Investments's portfolio value fell 56% quarter-over-quarter to $20.1B.
Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.